3645 results for «566»
3645 results
Unusual NSTEMI
18 May 2023 – From EuroPCR 2023
Embark on an exploration of unusual NSTEMI cases, where extraordinary interventions and innovative approaches redefine patient care: witness the life-saving use of ECMO in acute coronary occlusion and cardiac arrest, delve into the complexities of multivessel PCI in patients with global vascular disease and renal dysfunction,...
EuroPCR 2023 Hotlines/Late-Breaking Trials: focus on stent technology
17 May 2023 – From EuroPCR 2023
If you would like to learn more about the latest findings on stent techhnology, check-out this session in which speakers reviewed a series of recent trials, among them: 12-month primary endpoint outcomes of the BIOADAPTOR-RCT; Final 5-year results from the blinded ABSORB IV trial ; BIOMAG-I:...
PCI for complex coronary lesions
18 May 2023 – From EuroPCR 2023
Gain valuable insights into the management of challenging coronary lesions during PCI in this session: witness the effective treatment of in-stent restenosis through the innovative use of intravascular lithotripsy, explore the techniques employed to address non-expandable stents, discover the utility of the Guide Extension catheter system...
How to treat coronary aneurysm
18 May 2023 – From EuroPCR 2023
Treating coronary aneurysms requires careful consideration and depends on several facors such as specifics characteristics of the aneurysms and patient’s conditions. Learn more the way to treat them throught this series of cases: massive thrombosis of an RCA aneurysm ; new insight toward understanding WOVEN like...
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
